• Olsalazine Sodium: Reliable Cell Assay Design

  2026-08-31

  This scenario-driven guide explains how biomedical researchers can use Olsalazine Sodium, SKU A8490, in cell viability, proliferation, cytotoxicity, inflammation, and colorectal cancer workflows. It focuses on mechanism-aware controls, aqueous preparation, storage, interpretation, and practical vendor-selection criteria.

• ATP Solution in p21 mRNA-LNP Assays

  2026-08-30

  Discover how ATP Solution supports the assay architecture behind p21 mRNA-LNP research, from ATP-dependent enzymology and RNA production to phosphorylation readouts. This guide translates the study’s mechanistic findings into practical experimental decisions without confusing assay support with therapeutic evidence.

• Aurora A, SAM Metabolism, and Trained Immunity

  2026-08-29

  Li et al. identify Aurora kinase A as a regulator of β-glucan-trained immunity through an mTOR–FOXO3–GNMT pathway that controls endogenous S-adenosylmethionine availability. Their integrated chromatin, transcriptomic, metabolic, and in vivo experiments connect kinase activity with histone methylation, inflammatory gene priming, and the tumor-suppressive activity of trained macrophages.

• BRD4 Inhibition Promotes Erastin-Induced Ferroptosis

  2026-08-28

  The 2024 Discover Oncology study shows that pharmacologic or genetic BRD4 inhibition sensitizes multiple cell lines to erastin-induced ferroptosis. Its central mechanistic contribution is the identification of increased ROS and reduced FSP1 as shared features across models, despite cell-specific changes in other ferroptosis-associated genes.

• CFDA SE Cell Tracer Kit: Practical Guide

  2026-08-28

  The CFDA SE Cell Tracer Kit provides stable fluorescent labeling for cell lineage tracing, cell proliferation studies, and related in vitro or in vivo workflows. It is intended for persistent covalent marking and should not be selected for reversible, short-term labeling or experiments requiring continuous dye replenishment.

• Ibrexafungerp: From pH Biology to Translation

  2026-08-28

  Ibrexafungerp, also known as MK 3118, illustrates how mechanism, local microenvironment, and resistance biology must be integrated when advancing antifungal candidates. This article interprets pH-dependent susceptibility findings and translates them into practical workflows for VVC, resistant Candida, and future invasive candidiasis research.

• Zoledronic Acid: Mechanism-Led Assay Design

  2026-08-27

  Zoledronic Acid is a nitrogen-containing bisphosphonate widely studied in cancer and bone biology. This mechanism-led guide connects apoptosis assay design with causal pathway analysis, using recent immunometabolism research to sharpen experimental interpretation without overstating translational evidence.

• RNA Clean and Concentrator Kit for mRNA QC

  2026-08-27

  The RNA Clean and Concentrator Kit provides a rapid, membrane-based approach to RNA purification from enzymatic reactions. This article explains how disciplined in vitro transcription RNA cleanup can strengthen mRNA-LNP and engineered-cell studies, using TNF-α antibody delivery for intervertebral disc degeneration as a practical case.

• Gamma-Linolenic Acid in Translational Inflammation

  2026-08-26

  Gamma-linolenic acid (GLA) offers translational researchers a mechanistically distinctive way to connect leukotriene signaling, lipid metabolism, cell-state readouts, and clinically relevant inflammatory models. This thought-leadership perspective translates its evidence profile into practical assay strategy while emphasizing controls, reproducibility, and the limits of cross-domain interpretation.

• Cholecystokinin Octapeptide Ammonium: Assay Logic

  2026-08-26

  Cholecystokinin octapeptide ammonium is a sulfated brain–gut peptide for dissecting receptor-specific signaling, opioid-linked anxiety, and context-dependent cellular responses. This guide translates key rat findings into practical assay controls while defining the limits of cross-model interpretation.

• Isoprenaline Hydrochloride in Heart–Brain Research

  2026-08-25

  Isoprenaline Hydrochloride, also known as isoproterenol, provides a controllable way to activate β1- and β2-adrenergic signaling across cardiac, vascular, and neurobehavioral models. This guide translates heart–brain axis findings into practical workflows, assay controls, and troubleshooting decisions.

• NADH/NAD⁺ Redox Imbalance in Diabetic Kidney Disease

  2026-08-24

  Yan’s 2021 review identifies NADH/NAD⁺ redox imbalance as a unifying mechanism linking altered glucose metabolism, mitochondrial dysfunction, oxidative stress, and diabetic kidney disease. Its pathway-based analysis helps researchers interpret metabolic sources of excess NADH, assess mitochondrial consequences, and design more targeted studies without treating the review as direct clinical or experimental proof.

• Adamtsl3, MMP9, and Cortical Plasticity

  2026-08-24

  This study identifies Adamtsl3 as a cell-autonomous regulator of perineuronal-net integrity in parvalbumin-positive interneurons and connects its loss to elevated MMP9 activity, oxidative stress, and renewed adult cortical plasticity. The work provides a mechanistic framework for studying schizophrenia-associated extracellular-matrix dysfunction while highlighting the need to validate MMP9-directed interventions in disease-relevant models.

• (-)-JQ1: A Rigorous BET Inactive Control

  2026-08-23

  (-)-JQ1 is the matched inactive JQ1 stereoisomer for separating BET bromodomain-dependent biology from scaffold, solvent, and assay artifacts. This guide shows how to build it into cancer cell, reporter, and combination-treatment workflows without confusing a negative control with proof of target specificity.

• Necrosulfonamide: Mapping Calcium-Driven Necroptosis

  2026-08-22

  Necrosulfonamide provides a mechanistic way to test whether calcium and mitochondrial stress culminate in MLKL-dependent necroptosis. This article connects NSA with recent ischemia–reperfusion findings and shows how to interpret pathway-rescue data without confusing upstream injury with terminal membrane execution.

449 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page